In Ebola-hit West Africa, Indian pharma to showcase its wares

 Even as the Ebola virus disease outbreak in West Africa is causing worldwide concern, the Indian pharmaceutical industry is set to expand its footprint in the region with its first ever exhibition outside India.

US pharma companies want dialogue with India on IPRs

Patents system is very important for encouraging many aspects of innovation.

US exports may drive top Indian pharma cos to grow 20% in 2013

Top Indian pharma players will continue to grow strongly at over 20 percent in 2013, primarily led by exports to the US market, India Ratings said in its outlook for the sector.

Pharma exports grew over 23% in 2011-12: Pharmexcil

Indian pharma exports grew by 23.34 percent in the last fiscal, Pharmaceuticals Export Promotion Council of India (Pharmexcil) said Wednesday.

New drug pricing policy may impact MNCs most: Analysts

The new pricing policy finalised by the group of ministers last week will take the number of essential drugs under price control regime to as many as 348.

Bringing more essential drugs under control a fair policy:CII

Earlier this week, a Group of Ministers (GoM) approved a proposal to bring 348 essential drugs under government control.

Pharma cos need aggressive R&D and patent filing: Experts

Indian pharmaceutical companies need to go for aggressive research and patent filing, like China and Japan, industry experts said.

Incentive needed for enhancing spending on R&D: Pharma sector

The pharmaceutical industry has asked the Centre to incentivise the sector to promote higher spending in research and development and bring down taxes and duties on life saving drugs and active pharmaceutical ingredients (API) to provide a fillip to its growth.

India among top 10 global pharma markets by 2020: PwC

India will join the league of top 10 global pharmaceuticals markets in terms of sales by 2020 with the total value reaching $50 billion by then, according to a report by PricewaterhouseCoopers (PwC).